CD8+ Cells Enhance Resistance to Pulmonary Serotype 3 Streptococcus pneumoniae Infection in Mice

Despite the success of the pneumococcal conjugate vaccine, pneumococcal pneumonia remains a significant clinical problem, and there is still much to learn about natural resistance and cellular immunity to pneumococcus. We investigated the role of T lymphocytes in resistance to serotype (ST) 3 Streptococcus pneumoniae in an intranasal infection model in C57BL/6 (wild-type [Wt]) and CD8+ (CD8−/−)- and CD4+ (MHC class II−/−)-deficient mice. CD8−/− mice exhibited significantly more bacterial dissemination and lung inflammation and a significantly more lethal phenotype than Wt mice. However, there was no difference in the bacterial dissemination, lung inflammation, or survival of Wt and MHC class II−/− mice. Perforin (Pfn)−/− and IFN-γ−/− mice, which were used to dissect the role of CD8+ T cells in our model, also exhibited a more lethal survival phenotype than Wt mice. Comparison of lung chemokine/cytokine levels by Luminex and cellular recruitment by FACS in Wt mice and knockout strains revealed that CD8−/− and IFN-γ−/− mice, which had the most lethal survival phenotype, had more CD4+IL-17+ T (Th17) cells, IL-17, neutrophil chemoattractants, and lung neutrophils, and fewer regulatory T cells than Wt mice. CD4+ T cell depletion improved the survival of ST-infected CD8−/− mice, and survival studies in Th17-deficient mice revealed that the Th17 response was dispensable for ST3 resistance in our model. Taken together, these findings demonstrate that CD8+ cells are required, but CD4+ T cells are dispensable for resistance to ST3 pneumonia in mice and suggest a previously unsuspected role for CD8+ cells in modulating the inflammatory response to ST3.

[1]  E. Davila,et al.  When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function. , 2010, Blood.

[2]  A. McMichael,et al.  TLR2 engagement on memory CD8+ T cells improves their cytokine‐mediated proliferation and IFN‐γ secretion in the absence of Ag , 2009, European journal of immunology.

[3]  M. Starnbach,et al.  CD8+ T Cells Restrict Yersinia pseudotuberculosis Infection: Bypass of Anti-Phagocytosis by Targeting Antigen-Presenting Cells , 2009, PLoS pathogens.

[4]  E. Gelfand,et al.  Antigen Specificity Is not Required for Modulation of Lung Allergic Responses by Naturally Occurring Regulatory T Cells1 , 2009, The Journal of Immunology.

[5]  Thomas B. Clarke,et al.  Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. , 2009, The Journal of clinical investigation.

[6]  J. Poolman,et al.  Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics. , 2009, Vaccine.

[7]  Amit Awasthi,et al.  Th17 cells: from precursors to players in inflammation and infection. , 2009, International immunology.

[8]  T. Welte,et al.  Important Role for CC Chemokine Ligand 2-Dependent Lung Mononuclear Phagocyte Recruitment to Inhibit Sepsis in Mice Infected with Streptococcus pneumoniae 1 , 2009, The Journal of Immunology.

[9]  D. Reen,et al.  Activated Human Neonatal CD8+ T Cells Are Subject to Immunomodulation by Direct TLR2 or TLR5 Stimulation1 , 2009, The Journal of Immunology.

[10]  M. Richter,et al.  Cytokine synergy in antigen-independent activation and priming of naive CD8+ T lymphocytes. , 2009, Critical reviews in immunology.

[11]  M. Lipsitch,et al.  Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization , 2008, PLoS pathogens.

[12]  F. Lund Cytokine-producing B lymphocytes-key regulators of immunity. , 2008, Current opinion in immunology.

[13]  R. Flavell,et al.  Regulatory Role of B Cells in a Murine Model of Allergic Airway Disease1 , 2008, The Journal of Immunology.

[14]  T. van der Poll,et al.  Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation. , 2008, The Journal of infectious diseases.

[15]  W. Schaffner,et al.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. , 2007, The Journal of infectious diseases.

[16]  Francesco Bistoni,et al.  IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistance , 2007, European journal of immunology.

[17]  M. Lipsitch,et al.  Antibody-Independent, CD4+ T-Cell-Dependent Protection against Pneumococcal Colonization Elicited by Intranasal Immunization with Purified Pneumococcal Proteins , 2007, Infection and Immunity.

[18]  M. Farley,et al.  Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  P. Arbogast,et al.  Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis , 2007, The Lancet.

[20]  L. Pirofski,et al.  Influence of Neutropenia on the Course of Serotype 8 Pneumococcal Pneumonia in Mice , 2007, Infection and Immunity.

[21]  L. Pirofski,et al.  Pneumococcal Capsular Polysaccharide Vaccine-Mediated Protection against Serotype 3 Streptococcus pneumoniae in Immunodeficient Mice , 2007, Infection and Immunity.

[22]  D. Metzger,et al.  Interleukin-12 Promotes Gamma Interferon-Dependent Neutrophil Recruitment in the Lung and Improves Protection against Respiratory Streptococcus pneumoniae Infection , 2007, Infection and Immunity.

[23]  M. Lipsitch,et al.  Antibody-Independent, Interleukin-17A-Mediated, Cross-Serotype Immunity to Pneumococci in Mice Immunized Intranasally with the Cell Wall Polysaccharide , 2006, Infection and Immunity.

[24]  Andrew Pavia,et al.  Impact of the Pneumococcal Conjugate Vaccine on Pneumococcal Parapneumonic Empyema , 2006, The Pediatric infectious disease journal.

[25]  S. Swain,et al.  CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice. , 2006, The American journal of pathology.

[26]  K. Eriksson,et al.  CD8+ T-cells suppress antigen-specific and allogeneic CD4+ T-cell responses to herpes simplex virus type 2-infected human dendritic cells. , 2005, Viral immunology.

[27]  M. Stadecker,et al.  Severe CD4 T Cell-Mediated Immunopathology in Murine Schistosomiasis Is Dependent on IL-12p40 and Correlates with High Levels of IL-171 , 2005, The Journal of Immunology.

[28]  J. Shellito,et al.  T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice , 2005, The Journal of Immunology.

[29]  J. Shellito,et al.  Erratum: T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice (Journal of Immunology (2004) 172 (1132-1138)) , 2005 .

[30]  K. Haas,et al.  B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. , 2005, Immunity.

[31]  P. Andrew,et al.  Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts. , 2005, Microbes and infection.

[32]  M. Lipsitch,et al.  CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Q. Hamid,et al.  Resident CD8+ T cells suppress CD4+ T cell-dependent late allergic airway responses. , 2005, The Journal of allergy and clinical immunology.

[34]  K. Kawakami,et al.  Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of interferon-gamma. , 2004, Microbes and infection.

[35]  P. Sundstrom Faculty Opinions recommendation of Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. , 2004 .

[36]  T. Benfield,et al.  Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited , 2004, BMC infectious diseases.

[37]  P. Andrew,et al.  CD4-T-Lymphocyte Interactions with Pneumolysin and Pneumococci Suggest a Crucial Protective Role in the Host Response to Pneumococcal Infection , 2004, Infection and Immunity.

[38]  A. Gurney,et al.  Compromised Humoral and Delayed-Type Hypersensitivity Responses in IL-23-Deficient Mice1 , 2004, The Journal of Immunology.

[39]  D. Kasper,et al.  Zwitterionic Polysaccharides Stimulate T Cells with No Preferential Vβ Usage and Promote Anergy, Resulting in Protection against Experimental Abscess Formation1 , 2004, The Journal of Immunology.

[40]  J. Shellito,et al.  T Cytotoxic-1 CD8+ T Cells Are Effector Cells against Pneumocystis in Mice1 , 2004, The Journal of Immunology.

[41]  A. Melegaro,et al.  The 23-Valent Pneumococcal Polysaccharide Vaccine. Part I. Efficacy of PPV in the Elderly: A Comparison of Meta-Analyses , 2003, European Journal of Epidemiology.

[42]  E. Pamer,et al.  CD8 T cell responses to infectious pathogens. , 2003, Annual review of immunology.

[43]  G. Deepe,et al.  Vaccine Immunity to Pathogenic Fungi Overcomes the Requirement for CD4 Help in Exogenous Antigen Presentation to CD8+ T Cells , 2003, The Journal of experimental medicine.

[44]  T. van der Poll,et al.  Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. , 2003, American journal of respiratory and critical care medicine.

[45]  M. Wüthrich,et al.  Requisite Elements in Vaccine Immunity to Blastomyces dermatitidis: Plasticity Uncovers Vaccine Potential in Immune-Deficient Hosts1 2 , 2002, The Journal of Immunology.

[46]  J. Simecka,et al.  Depletion of CD8+ T Cells Exacerbates CD4+ Th Cell-Associated Inflammatory Lesions During Murine Mycoplasma Respiratory Disease1 , 2002, The Journal of Immunology.

[47]  S. Deventer,et al.  The Role of Interferon-γ in Murine Pneumococcal Pneumonia , 2002 .

[48]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[49]  M. Bergeron,et al.  Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. , 2001, The Journal of infectious diseases.

[50]  M. Bergeron,et al.  Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia. , 2000, The Journal of infectious diseases.

[51]  J. Rubins,et al.  Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia , 1997, Infection and immunity.

[52]  J. Curtis,et al.  Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. , 1993, The Journal of laboratory and clinical medicine.

[53]  D. Gray,et al.  Mice lacking MHC class II molecules , 1991, Cell.

[54]  D. Littman,et al.  A second subunit of CD8 is expressed in human T cells. , 1988, The EMBO journal.